Back-To-School: Mannatech’s Ambrotose Powder Boosts Cognitive Functions to Support Student Success

COPPELL, Texas–(BUSINESS WIRE)–Mannatech®,
(NASDAQ: MTEX), a global health and wellness company
committed to transforming lives to make a better world, offers the
innovative nutritional supplement, Ambrotose®, which is
clinically proven to provide cognitive support for young adult functions
essential for students to reach their potential in the classroom. With
students preparing to go back to school, Ambrotose powder can be among
the many tools available for families with high school or college-aged
students seeking academic excellence.

According to human clinical trials published in peer reviewed journals,
Ambrotose powders can positively impact brainwaves associated with
attention in young adults and improve memory and alertness in
middle-aged adults.*

The cognitive factors of focus, attention and memory are crucial for
young adult students aiming for high academic achievement.

“Clinical studies conducted by independent scientists who are experts in
their fields have found that Ambrotose powder gives a helpful boost in
memory, focus and attention as well as providing perceived beneficial
changes in well-being,” said Dr. Rolando Maddela, MD, MPH, CCRP,
Mannatech’s Director of Clinical Research and Scientific Affairs. “For
young adults who are students, Ambrotose products can be a positive
addition to a comprehensive approach to academic achievement. Ambrotose
may also play an important role in the overall health and wellness of
students, a factor that also contributes to academic success.”*

Dr. Maddela suggests that as little as four grams per day of Advanced
Ambrotose® powder or Ambrotose Complex can help support some
of the factors that contribute to success in the classroom.*

Mannatech is the pioneer in developing Glyconutritional technology,
which includes Ambrotose powders. Ambrotose encourages cellular
communication and is shown to support cognitive functions – including
memory, focus and attention, as well as supporting the body’s immune and
digestive systems to encourage overall health.*

Many of Mannatech’s Glyconutritional products are supported by
industry-standard clinical studies, including 17 human clinical trials
that have been published, 12 of which were double-blind,
placebo-controlled studies — the gold standard for product validation.
For more on Mannatech’s rigorous scientific research, go to

and Ambrotose
powders are clinically tested to improve cognitive function
and support the body’s immune system.*

Additionally, for students that need to keep going strong during long
study sessions, Mannatech offers MannaBOOM™
. MannaBOOM Slimsticks are packed with naturally-sourced
antioxidants, and Mannatech’s core Glyconutrient ingredients. The
slimsticks can be taken anywhere, anytime and give a quick, powerful
boost to the immune system with glyconutrients and an herbal blend of
plant and food-sourced vitamin C.*

To begin transforming your life or the lives of those around you, please

*These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat, cure
or prevent any disease.

About Mannatech

Mannatech, Incorporated, offers a profound wellness experience through a
financially rewarding opportunity that makes a difference in the lives
of people across the world. Through its innovative glyconutrition
products, Mannatech transforms lives, providing an unprecedented level
of natural wellness, freedom and purpose. With more than 20 years of
experience and operations in more than 25 countries, Mannatech is
committed to transforming lives. For more information, visit

Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain associates and
members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.


Mannatech, Incorporated
Kalyn Dabbs, 972-471-7245